Wellgistics Health, Inc. (WGRX)
Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014Q1-CY2014Q4-CY2013
Balance Sheet Date2025-Sep-302025-Jun-302025-Mar-312024-Dec-31
Fiscal PeriodQ3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024
Close Price of Common Stock0.50$0.88$0.96$4.34$
Market Cap of Common Stock44,747,992$74,379,916$69,338,201$225,438,683$
QoQ%(39.84%)7.27%(69.24%)
YoY%
Common Shares Outstanding89,729,28189,452,91163,144,81761,460,01451,055,50851,055,50847,056,17344,720,00044,720,000
QoQ%.31%41.66%2.74%20.38%.00%8.50%5.22%.00%
YoY%75.75%75.21%34.19%37.43%14.17%
Price to Sales1.31x2.18x1.89x7.78x
Price to Earnings----
Price to Book6.60x10.97x76.60x50.33x
Total Revenue3,012,904$7,790,865$10,863,443$12,410,423$5,673,868$44,540$
QoQ%(61.33%)(28.28%)(12.47%)118.73%12,638.82%
YoY%(46.90%)17,391.84%
TTM34,077,635$36,738,599$28,992,274$
TTM_QoQ%(7.24%)26.72%
TTM_YoY%
Gross Margin7.67%6.49%6.38%10.06%9.19%(5.86%)
QoQ1.18%.12%(3.69%).88%15.04%
YoY(1.52%)12.35%
Operating Income(31,548,329$)(5,500,376$)(31,348,368$)(3,747,532$)(1,744,820$)(573,016$)(79,764$)
QoQ%(473.57%)82.45%(736.51%)(114.78%)(204.50%)(618.39%)
YoY%(1,708.11%)(859.90%)(39,201.40%)
TTM(72,144,605$)(42,341,096$)(37,413,736$)(6,145,132$)
TTM_QoQ%(70.39%)(13.17%)(508.84%)
TTM_YoY%
Operating Margin(1,047.11%)(70.60%)(288.57%)(30.20%)(30.75%)(1,286.52%)
QoQ(976.51%)217.97%(258.37%).56%1,255.77%
YoY(1,016.36%)1,215.92%
Net Income(34,318,204$)(6,672,464$)(32,430,903$)(4,331,752$)(1,867,027$)(574,325$)(83,122$)
QoQ%(414.33%)79.43%(648.68%)(132.01%)(225.08%)(590.94%)
YoY%(1,738.12%)(1,061.79%)(38,916.03%)
TTM(77,753,323$)(45,302,146$)(39,204,007$)(6,856,226$)
TTM_QoQ%(71.63%)(15.56%)(471.80%)
TTM_YoY%
Profit Margin(1,139.04%)(85.65%)(298.53%)(34.90%)(32.91%)(1,289.46%)
QoQ(1,053.40%)212.89%(263.63%)(2.00%)1,256.55%
YoY(1,106.14%)1,203.81%
Equity to Common Shareholders6,778,015$905,255$4,478,768$6,734,446$9,985,092$(3,147,881$)(2,983,556$)(2,900,434$)
QoQ5,872,760$(3,573,513$)(2,255,678$)(3,250,646$)13,132,973$(164,325$)(83,122$)
QoQ%648.74%(79.79%)(33.50%)(32.56%)417.20%(5.51%)(2.87%)
YoY(3,207,077$)4,053,136$7,462,324$9,634,880$
YoY%(32.12%)128.76%250.12%332.19%
Dividends Paid
Additional Paid-In Capital QoQ40,188,334$3,098,782$30,174,184$
Treasury Stock
QoQ
Goodwill16,219,929$16,219,929$16,219,929$16,219,929$
QoQ%.00%.00%.00%
YoY%
Other Intangible Assets18,456,815$19,219,880$19,982,945$20,746,009$
QoQ(763,065$)(763,065$)(763,064$)
Amortization of Intangible Assets12,308$12,308$12,308$
Total Assets52,779,540$54,225,015$58,063,100$57,332,650$338,364$
QoQ(1,445,475$)(3,838,085$)730,450$
YoY56,994,286$
Total Liabilities46,001,525$53,319,760$53,584,332$50,598,204$3,238,798$
QoQ(7,318,235$)(264,572$)2,986,128$
YoY47,359,406$
Current Ratio.39x.32x.36x.40x.12x
Total Current Assets12,820,490$13,509,643$16,551,732$15,168,668$338,364$
QoQ(689,153$)(3,042,089$)1,383,064$
Total Current Liabilities32,741,039$42,403,542$46,225,313$38,046,747$2,888,798$
QoQ(9,662,503$)(3,821,771$)8,178,566$
Debt to Asset Ratio.87x.98x.92x.88x9.57x
Long Term Debt12,600,000$10,100,000$24,123,339$11,455,085$
QoQ2,500,000$(14,023,339$)12,668,254$
YoY
Capital Lease Obligations1,249,096$1,472,249$1,775,142$
Cash and Cash Equivalents4,228,666$419,942$2,516,585$1,028,336$1,364$
QoQ3,808,724$(2,096,643$)1,488,249$
YoY1,026,972$
Interest Expenses
Interest Income